Serum amyloid a, a potential biomarker both in serum and tissue, correlates with ovarian cancer progression

BACKGROUND: Ovarian cancer is the most fatal gynecologic malignancy worldwide due to its vagueness, delay in diagnosis, recurrence, and drug resistance. Therefore, a new type of ovarian cancer treatment prediction biomarker is urgently needed to supplement existing tools. A total of 230 people parti...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ze, Hou, Yongwang, Zhao, Meng, Li, Tianning, Liu, Yahui, Chang, Jiao, Ren, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285470/
https://www.ncbi.nlm.nih.gov/pubmed/32517794
http://dx.doi.org/10.1186/s13048-020-00669-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285470/
https://www.ncbi.nlm.nih.gov/pubmed/32517794
http://dx.doi.org/10.1186/s13048-020-00669-w

Ejemplares similares